What is Tirzepatide?
Tirzepatide, marketed under the brand name Mounjaro®, is a dual-action medication that targets both the GLP-1 and GIP receptors—two key hormones involved in regulating blood sugar and appetite. This unique mechanism of action distinguishes it from other weight loss medications and has yielded promising results in clinical studies.
Originally approved for the treatment of type 2 diabetes, Tirzepatide has rapidly gained attention for its remarkable weight loss benefits. In trials, some patients experienced more weight loss than with Semaglutide alone, making it a strong option for those needing enhanced support in their weight loss journey.
Tirzepatide is typically administered as a weekly injection and is suitable for individuals with or without diabetes who meet specific BMI and health criteria. Our team at HTX Urology will determine the most appropriate medication based on your medical history and weight loss goals.